Exhibit 16.1
Deloitte & Touche LLP | |
200 Berkeley Street | |
Boston, MA | |
02116 USA | |
Tel.: +1 617 473 2000 | |
www.deloitte.com |
July 15, 2022
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of Eloxx Pharmaceuticals, Inc.'s Form 8-K dated July 15, 2022, and we agree with the statements made in paragraphs 2, 3, 4, and 5 therein. We have no basis to agree or disagree with the statements made in paragraphs 1 and 6.
Yours truly,
Deloitte & Touche LLP